Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6405
Reference
Drug alert 01/2019
Name
Drug alert class 2 no 01 2019: action within 48 hours: Actavis Group Ptc Ehf, Irbesartan /Hydrochlorothiazide 300 / 12.5mg film-coated tablets; Irbesartan / Hydrochlorothiazide 150 / 12.5mg film-coated tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Actavis Group PTC EHF is recalling four batches from pharmacies as a precautionary measure due to possible contamination with N.nitrosodiethylamine (NDEA).
Contact Name
Alison Strath
Contact Email
Contact Address
Principal Pharmaceutical Officer, Pharmacy and Medicines Division, St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2019-01-03 00:00:00
Click to go back to homepage